Amgen Valuation

Amgen Inc -- USA Stock  

USD 186.64  0.88  0.47%

Amgen Inc shows prevailing Real Value of $201.11 per share. The current price of the firm is $186.64. At this time the firm appears to be under valued. Macroaxis approximates value of Amgen Inc from analyzing the firm fundamentals such as Profit Margin of 35.46% and Return On Equity of 26.43% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.

Valuation Drivers Correlation

Selected Amgen Inc Valuation Data Over Time

Net Income Per Employee    Enterprise Value    Market Capitalization    
Investment Horizon     30 Days    Login   to change
Amgen Inc is rated second in five year return category among related companies. It is rated below average in price to earning category among related companies reporting about  8.80  of Price to Earning per Five Year Return.
Under Valued
September 24, 2017
186.64
Market Value
Downside upside
Downside
169.35
201.11
Real Value
Target Price Odds
 Above  Below  
204.65
Upside
Upside upside
Amgen is not too risky asset. Calculation of real value of Amgen Inc is based on 1 month time horizon. Increasing Amgen Inc time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Recommendations

Amgen Analyst Recommendations
Target PriceAdvice# of Analysts
183.83Hold12Odds
Amgen Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Amgen Analyst Advice  

Tax Efficiency

Amgen Inc Tax Efficiency History

Tax Efficiency

Market Capitalization

Amgen Market Capitalization Analysis
Amgen Inc is number one stock in market capitalization category among related companies. Market capitalization of Pharmaceuticals And Biosciences industry is presently estimated at about 362.99 Billion. Amgen totals roughly 136.06 Billion in market capitalization claiming about 37% of equities listed under Pharmaceuticals And Biosciences industry.
Capitalization  Valuation  Total debt  Revenue  Workforce

Revenue

Amgen Inc Revenue
Based on latest financial disclosure Amgen Inc reported 23.05 B of revenue. This is 254.62% higher than that of the Healthcare sector, and significantly higher than that of Pharmaceuticals And Biosciences industry, The Revenue for all stocks is 134.09% lower than the firm.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.